نتایج جستجو برای: responses to vaccine

تعداد نتایج: 10698432  

ژورنال: :jundishapur journal of microbiology 0
fatemeh tabatabaie department of parasitology and mycology, school of medicine, iran university of medical sciences (iums), tehran, ir iran mehdi mahdavi department of virology, pasteur institute of iran, tehran, ir iran sobhan faezi department of bacteriology, pasteur institute of iran, tehran, ir iran abdolhossein dalimi department of parasitology, faculty of medical sciences, tarbiat modares university, tehran, ir iran zohreh sharifi blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran lame akhlaghi department of parasitology and mycology, school of medicine, iran university of medical sciences (iums), tehran, ir iran

background: the thiol-specific antioxidant (tsa) is an antigen of leishmania major which is believed to be the most promising molecule as a vaccine candidate against leishmaniasis. objectives: in this study, we investigated the protective efficacy of tsa-based dna vaccine against l. major infection. materials and methods: recombinant plasmid construction tsa (pctsa) was prepared and transfected...

Journal: :The Journal of infectious diseases 2015
Genevieve G Fouda Coleen K Cunningham Elizabeth J McFarland William Borkowsky Petronella Muresan Justin Pollara Lin Ye Song Brooke E Liebl Kaylan Whitaker Xiaoying Shen Nathan A Vandergrift R Glenn Overman Nicole L Yates M Anthony Moody Carrie Fry Jerome H Kim Nelson L Michael Merlin Robb Punnee Pitisuttithum Jaranit Kaewkungwal Sorachai Nitayaphan Supachai Rerks-Ngarm Hua-Xin Liao Barton F Haynes David C Montefiori Guido Ferrari Georgia D Tomaras Sallie R Permar

BACKGROUND Infant responses to vaccines can be impeded by maternal antibodies and immune system immaturity. It is therefore unclear whether human immunodeficiency virus type 1 (HIV-1) vaccination would elicit similar responses in adults and infants. METHOD HIV-1 Env-specific antibody responses were evaluated in 2 completed pediatric vaccine trials. In the Pediatric AIDS Clinical Trials Group ...

Journal: :applied biotechnology reports 0
seyed mohammad gheibi hayat azam sadeghinia shahram nazarian zahra adeli

an adjuvant is a substance that is added to a vaccine to increase the body's immune response to the vaccine. vaccines containing adjuvants are tested for safety in clinical trials before they are licensed for used. the basic action of adjuvants is stimulating adaptive immune responses. adjuvants, recently licensed for human utlization, involve alum squalane oil or water emulsion, influenza viro...

Journal: :reports of biochemistry and molecular biology 0
atieh yaghoubi antimicrobial resistance research center, mashhad university of medical sciences, mashhad, iran ehsan aryan antimicrobial resistance research center, mashhad university of medical sciences, mashhad, iran hosna zare antimicrobial resistance research center, mashhad university of medical sciences, mashhad, iran shadi alami antimicrobial resistance research center, mashhad university of medical sciences, mashhad, iran roghayeh teimourpour department of microbiology, school of medicine, ardabil university of medical sciences, ardabil, iran. zahra meshkat tel: +98 51 38012453; fax: +98 51 38002960

background: tuberculosis (tb) is a major cause of death worldwide. finding an effective vaccine against tb is the best way to control it. several vaccines against this disease have been developed but none are completely protective. the aim of this study was to design and construct a cloning vector containing the mycobacterium tuberculosis (m. tuberculosis) heat shock protein x (hspx). methods: ...

Behnaz Gharegozlou Mohsen Mohammadi Sussan Kaboudanian Ardestani, Zahra Kianmehr

Background: Adjuvants are used to increase the immunogenicity of new generation vaccines, especially those based on recombinant proteins. Despite immunostimulatory properties, the use of bacterial lipopolysaccharide (LPS) as an adjuvant has been hampered due to its toxicity and pyrogenicity. Brucella abortus LPS is less toxic and has no pyrogenic properties compared to LPS from other gram nega...

Journal: :iranian journal of basic medical sciences 0
amir ghasemi molecular biology research center, baqiyatallah university of medical sciences, tehran, iran reza ranjbar applied microbiology research center, baqiyatallah medical science university, tehran, iran jafar amani molecular biology research center, baqiyatallah university of medical sciences, tehran, iran

objective(s):brucellosis, especially caused by brucella melitensis, remains one of the most common zoonotic diseases worldwide with more than 500,000 human cases reported annually. the commonly used live attenuated vaccine in ovine brucellosis prophylaxis is b. melitensis rev1. but due to different problems caused by the administration of this vaccine, a protective subunit vaccine against b. me...

Journal: :iranian journal of allergy, asthma and immunology 0
azam ghaziasadi hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, iran seyed moayed alavian baqiyatallah university of medical sciences, baqiyatallah research centre for gastroenterology and liver disease, tehran, iran mahdi norouzi hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, iran zeinab fazeli hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, iran seyed mohammad jazayeri hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, iran

hepatitis b vaccination is safe and effective, although breakthrough infection occasionally occurs in those who receive the vaccine and hepatitis b immunoglobulin (hbig) prophylaxis. sequence variation in their antigenic regions is one of the most powerful strategies that are used by viruses to escape recognition by b and t cell-mediated immune responses. the aim of this study was to explore th...

Journal: :poultry science journal 2014
sanganagouda k naveen an shivaraj m dhinakarraj g

this experiment was conducted for evaluating the humoral immune responses induced by poly lactide-co-glycolide acid (plga) microspheres coupled inactivated newcastle disease virus (ndv) vaccine in comparison to an ‘in-house’ prepared inactivated and a live commercial vaccine. plg microparticles containing inactivated ndv were prepared by a double emulsion technique based on solvent evaporation ...

Journal: :Journal of immunology 2004
Rana A K Singh Michael A Barry

Several gene-based vaccine approaches are being tested to drive multivalent cellular immune responses to control HIV-1 viral variants. To compare the utility of these approaches, HLA-A*0201 transgenic mice were genetically immunized with plasmids encoding wild-type (wt) gag-pol, codon-optimized (CO) gag-pol, and an expression library immunization (ELI) vaccine genetically re-engineered to expre...

2018
Erin M Scherer Robin A Smith Joseph J Carter Gregory C Wipf Daniel F Gallego Michael Stern Anna Wald Denise A Galloway

Current guidance recommends that adolescents receive a 2-dose human papillomavirus (HPV) vaccine, whereas young adults and immunocompromised persons receive 3 doses. We examined secondary responses of vaccine-elicited memory B cells (Bmem) in naive women receiving 3 doses of the quadrivalent HPV vaccine to understand the quality of B-cell memory generated by this highly effective vaccine. Unexp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید